TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Bone resorption marker β‐carboxyterminal telopeptide of type I collagen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic accuracy of CEUS compared to TUS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean change in MDP from baseline to end of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean MAI score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Methylation rate of WWOX gene
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: 24-h invasion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: 24-h apoptotic rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Pain intensity regression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance on the 10-meter walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean platelet engraftment time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade II or above acute GVHD
Endpoint domain: Adverse events/effects
Primary endpoint: Area Under the Curve (AUC) for detection of acetabular wall
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postinjury firearm weapon carriage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in mean body weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in median total cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Body perception disturbance (BPD) reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete remission of lichen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Reduction in the area of evaluated lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Completion rate of colonoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Diagnosis of colorectal cancer
Endpoint domain: Mortality/survival
Primary endpoint: Development of new caries
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Impairment Weight (IW)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cost benefit expressed as return-on-investment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Shear modulus values of the posterior shoulder capsules
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Resolution of borderline or definite NASH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Progression to definite NASH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Satisfaction with the treatment effect
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: I‐FABPp levels for early identification of surgical NEC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: I‐FABPu levels for differentiating Bell's stage II from stage III
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in functional T-cell responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Long-term decline in antigen-specific TH1 responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: WMFT time improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parent-adolescent communication about sex-related topics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parent's sexual communication skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parent's self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cervical hysteresis changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decreased drinking for girls
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CPAP usage time in hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fat retention rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: volumetric shrinkage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MIO improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-∞
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Increase in TIL concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Myoelectric potential of TypeⅠmuscle fiber
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Maximum myoelectric potential of TypeⅡmuscle fibers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Levels of autonomy
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Bed net usage
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of mucosal pressure injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average daily nursing cost related to tracheal intubation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Catheter dislocation rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hand hygiene belief score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: handwashing skill score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in Montgomery‐Asberg Depression Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of emergence delirium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: 24-hour mean glucose values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 1-h postprandial glucose values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: New York Posture Rating chart test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Flamingo Balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sit and Reach
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of melasma score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: skin quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Narrative Language Test scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of conversational turns
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Cognitive performance measured by Baddeley verbal reasoning task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: mean weekly total pain burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neck pain score at day 3 after operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neck numbness and discomfort score at month 1 after operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: aesthetic satisfaction score at 3 months after operation
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Global spasticity improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Better motor function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: COVID-19 symptom frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Return to baseline functional state or improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: decrease in anxiety score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time to first EEDS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of citations
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: number of downloads
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reduction in doses of psychotropics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cost savings in psychotropic medication
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Improvement of VAS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Cholesterol change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lipid profiles outcomes
Primary endpoint: horizontal jumps distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of root resorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: all stroke
Endpoint domain: Mortality/survival
Primary endpoint: Mean decrease in BMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: JEV seroprotection rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Clavien ≥3 complications rate
Endpoint domain: Adverse events/effects
Primary endpoint: Mean number of relapses per patient
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preference for place of death (PPD)
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Airway rescue interventions
Endpoint domain: Adverse events/effects
Primary endpoint: Desaturation resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Need for additional sedatives
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: daily energy intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: gastrointestinal tolerance of enteral nutrition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Performance on the Letter-Digit Coding Test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Immediate recall on the 15-Picture Learning Test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Delayed recall on the 15-Picture Learning Test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: intensity of pain at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discontinuation of mirabegron
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of patients with a viral load of less than 200 copies per mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-care confidence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: maintenance and management
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Completion of stool blood test (SBT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion of any CRC screening test (SBT or colonoscopy)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean difference in ΔQTc interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Drill-hole appearance on plain radiographs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Drill-hole volume as estimated on CT images
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC of the PKU-ML model
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Quality of Life (QOL) summary scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: total retraction rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relapse rate of proliferative LN
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Severe SLE flares
Endpoint domain: Adverse events/effects
Primary endpoint: number of TPs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cold pressor pain tolerance (PTT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pain outcomes
Primary endpoint: Pressure pain tolerance (PTT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pain outcomes
Primary endpoint: Heat pain detection thresholds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pain outcomes
Primary endpoint: Odds of prior metformin use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Odds of long-term metformin use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SPADI improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved global functioning
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Reduced symptoms of anxiety and depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: acute adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: cosmetic effect
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: delivery of primary and secondary cancer prevention services
Endpoint domain: Resource use
Endpoint subdomain: Delivery of care
Primary endpoint: truncated binary outcomes
Endpoint domain: Adverse events/effects
Primary endpoint: Rotation angle of ICL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PASAT-3 score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of days required to optimize stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: aTSC measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: aTPC measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Denture stomatitis scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bleeding measured by drain output
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Hemoglobin (Hb) variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Occurrence of ecchymosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Grade of edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: EORTC QLQ-C30 Fatigue score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: VAS score at week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of polypharmacy
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Clinical success rate of primary molars
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: beep test performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LDLc reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Implant retention rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Serum concentration of HDL-C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum concentration of iPTH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Mechanical ventilation or death at thirty days
Endpoint domain: Mortality/survival
Primary endpoint: Improvement in IEF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in FI quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Reduction in FI burden
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Assertiveness towards avatar
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive sense of self
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Muscle strength of the lower flexor-extensor muscle of the knee joint
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Functional Movement Assessment (FMA) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Step speed and frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EXACT-RS total score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in RF (Reflective Functioning)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mortality associated with severe vitamin D deficiency
Endpoint domain: Mortality/survival
Primary endpoint: Osmolality-corrected urinary kidney injury molecule-1 (uKIM-1) concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Osmolality-corrected urinary neutrophil gelatinase-associated lipocalin (uNGAL) concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Improvement in work/study participation (WPL)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Associated indirect cost savings
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Immunogenicity against pertussis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: 2.4kmTT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximal aerobic speed (MAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: running endurance performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Joint health
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sPGA 0 or 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Itch Numeric Rating Scale improvement
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: decreased worry
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Behavioral/severity in CRF
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Mean Monthly Days (MMD) change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Monthly Severe Migraine Days (MSMD) change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients achieving response thresholds (≥50%, ≥75%, 100%)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: FMA-UE-Total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AROM-Elbow Extension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Proportion improved between treatments and controls
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: supragingival plaque scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rates of seroma development
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Patients requiring treatment for appendicitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in believability of encapsulated beliefs
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: 3-year relapse-free survival (RFS)
Endpoint domain: Mortality/survival
Primary endpoint: Use of long-acting reversible contraceptives (LARC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CO2 reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: dCA (dynamic cerebral autoregulation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Markers of autophagy in liver
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 7 day point abstinence at 3 months post-intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported anxiety levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Fibrosis improvement without worsening of NASH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cancer-related fatigue score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Prevalence of acute PTSD-YC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Loss of PTSD-YC diagnosis following CBT-3M
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiopulmonary hospitalizations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes